The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Activation of nuclear factor κB in inflammatory bowel disease
Open accessAbstract
Background —Expression of pro-inflammatory cytokines is increased in the intestinal lamina propria of patients with inflammatory bowel disease (IBD). Nuclear factor κB (NFκB) controls transcription of inflammation genes. On activation, NFκB is rapidly released from its cytoplasmic inhibitor (IκB), transmigrates into the nucleus, and binds to DNA response elements in gene promoter regions. Aims —To investigate whether increased activation of NFκB is important in IBD and may be down-regulated by anti-inflammatory treatment. Methods —Activation of NFκB was determined by western blot assessment and electrophoretic mobility shift assay in nuclear extracts of colonic biopsy samples as well as lamina propria mononuclear cells. Results —Nuclear levels of NFκB p65 are increased in lamina propria biopsy specimens from patients with Crohn’s disease in comparison with patients with ulcerative colitis and controls. Increased activation of NFκB was detected in lamina propria mononuclear cells from patients with active IBD. Corticosteroids strongly inhibit intestinal NFκB activation in IBD in vivo and in vitro by stabilising the cytosolic inhibitor IκBα against activation induced degradation. Conclusions —In both IBDs, but particularly Crohn’s disease, increased activation of NFκB may be involved in the regulation of the inflammatory response. Inhibition of NFκB activation may represent a mechanism by which steroids exert an anti-inflammatory effect in IBD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Molecular cloning: A laboratory manual
Deininger, P. (1990) · Analytical Biochemistry · doi:10.1016/0003-2697(90)90595-z · Cited by 84,682
On a Test of Whether one of Two Random Variables is Stochastically Larger than the Other
Mann, H. B., & Whitney, D. R. (1947) · The Annals of Mathematical Statistics · doi:10.1214/aoms/1177730491 · Cited by 14,320
THE NF-κB AND IκB PROTEINS: New Discoveries and Insights
Baldwin, A. S. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.649 · Cited by 4,979
On the Kolmogorov-Smirnov Test for Normality with Mean and Variance Unknown
Lilliefors, H. W. (1967) · Journal of the American Statistical Association · doi:10.2307/2283970 · Cited by 4,530
Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study.
Best, W. R., Becktel, J. M., Singleton, J. W., & Kern, F. (1976) · PubMed · Cited by 3,147
Auphan, N., DiDonato, J. A., Rosette, C., Helmberg, A., & Karin, M. (1995) · Science · doi:10.1126/science.270.5234.286 · Cited by 2,390
Inhibition of NF-κB by Sodium Salicylate and Aspirin
Kopp, E., & Ghosh, S. (1994) · Science · doi:10.1126/science.8052854 · Cited by 1,753
Role of Transcriptional Activation of IκBα in Mediation of Immunosuppression by Glucocorticoids
Scheinman, R. I., Cogswell, P. C., Lofquist, A. K., & Baldwin, A. S. (1995) · Science · doi:10.1126/science.270.5234.283 · Cited by 1,699
Osborn, L., Kunkel, S., & Nabel, G. J. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.7.2336 · Cited by 1,621
Cited by
NF-κB signaling in inflammation
Liu, T., Zhang, L., Joo, D., & Sun, S.-C. (2017) · Signal Transduction and Targeted Therapy · doi:10.1038/sigtrans.2017.23 · Cited by 8,791
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Hugot, J.-P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J.-P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., et al. (2001) · Nature · doi:10.1038/35079107 · Cited by 5,591
Activators and Target Genes of Rel/NF-кB Transcription Factors: From Bench to Bedside
Loop, T., & Pahl, H. L. (2003) · Nuclear Factor кB · doi:10.1007/978-94-010-0163-2_1 · Cited by 3,169
Dietary phenolics: chemistry, bioavailability and effects on health
Crozier, A., Jaganath, I. B., & Clifford, M. N. (2009) · Natural Product Reports · doi:10.1039/b802662a · Cited by 1,988
Potential beneficial effects of butyrate in intestinal and extraintestinal diseases
Canani, R. B. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i12.1519 · Cited by 1,381
Mucosal flora in inflammatory bowel disease
Swidsinski, A., Ladhoff, A., Pernthaler, A., Swidsinski, S., Loening–Baucke, V., Ortner, M., Weber, J., Hoffmann, U., Schreiber, S., Dietel, M., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.30294 · Cited by 1,346
Self-citationButyrate inhibits inflammatory responses through NFκB inhibition: implications for Crohn's disease
Segain, J.-P., de la Blétière, D. R., Bourreille, A., Leray, V, Gervois, N., Rosales, C., Ferrier, L., Bonnet, C., Blottière, H. M., & Galmiche, J.-P. (2000) · Gut · doi:10.1136/gut.47.3.397 · Cited by 1,321
Hampe, J., Cuthbert, A., Croucher, P. J., Mirza, M. M., Mascheretti, S., Fisher, S., Frenzel, H., King, K., Hasselmeyer, A., MacPherson, A. J., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(00)05063-7 · Cited by 1,092
Self-citationChronic inflammation: importance of NOD2 and NALP3 in interleukin-1β generation
Ferrero-Miliani, L., Nielsen, O. H., Andersen, P. S., & Girardin, S. E. (2007) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2006.03261.x · Cited by 1,079
Horror Autoinflammaticus: The Molecular Pathophysiology of Autoinflammatory Disease
Masters, S. L., Simon, A., Aksentijevich, I., & Kastner, D. L. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141627 · Cited by 1,065
The genetics and immunopathogenesis of inflammatory bowel disease
Cho, J. H. (2008) · Nature Reviews Immunology · doi:10.1038/nri2340 · Cited by 940
De Bosscher, K., Vanden Berghe, W., & Haegeman, G. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0006 · Cited by 898
Tedelind, S., Westberg, F., Kjerrulf, M., & Vidal, A. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i20.2826 · Cited by 853
Ormandy, L. A., Hillemann, T., Wedemeyer, H., Manns, M. P., Greten, T. F., & Korangy, F. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3232 · Cited by 642
The molecular classification of the clinical manifestations of Crohn's disease
Ahmad, T., Armuzzi, A., Bunce, M., Mulcahy–Hawes, K., Marshall, S. E., Orchard, T. R., Crawshaw, J., Large, O., De Silva, A., Cook, J. T., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.32413 · Cited by 617
NF‐κB signaling in inflammation and cancer
Zhang, T., Ma, C., Zhang, Z., Zhang, H., & Hu, H. (2021) · MedComm · doi:10.1002/mco2.104 · Cited by 574
The Genetics of Inflammatory Bowel Disease
Cho, J. H., & Weaver, C. T. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.08.032 · Cited by 552
Interleukin-10 Signaling Blocks Inhibitor of κB Kinase Activity and Nuclear Factor κB DNA Binding
Schottelius, A. J. G., Mayo, M. W., Sartor, R. B., & Baldwin, A. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.31868 · Cited by 532
Regulation of tissue homeostasis by NF-κB signalling: implications for inflammatory diseases
Pasparakis, M. (2009) · Nature Reviews Immunology · doi:10.1038/nri2655 · Cited by 523
NF-κB in the regulation of epithelial homeostasis and inflammation
Wullaert, A., Bonnet, M. C., & Pasparakis, M. (2011) · Cell Research · doi:10.1038/cr.2010.175 · Cited by 521
NF-κB in inflammation and cancer
Mao, H., Zhao, X., & Sun, S.-C. (2025) · Cellular & Molecular Immunology · doi:10.1038/s41423-025-01310-w · Cited by 489
Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease
Schreiber, S., Fedorak, R. N., Nielsen, O. H., Wild, G., Williams, C. N., Nikolaus, S., Jacyna, M., Lashner, B. A., Gangl, A., Rutgeerts, P., et al. (2000) · Gastroenterology · doi:10.1053/gast.2000.20196 · Cited by 458
Self-citationRosenstiel, P., Fantini, M., Bräutigam, K., Kühbacher, T., Waetzig, G. H., Seegert, D., & Schreiber, S. (2003) · Gastroenterology · doi:10.1053/gast.2003.50157 · Cited by 422
Self-citationPiechota-Polanczyk, A., & Fichna, J. (2014) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-014-0985-1 · Cited by 390
The IκB/NF-κB system: a key determinant of mucosal inflammation and protection
Jobin, C., & Sartor, R. B. (2000) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2000.278.3.c451 · Cited by 386
Role of NF-κB in immune and inflammatory responses in the gut
NEURATH, M. F., BECKER, C., & BARBULESCU, K. (1998) · Gut · doi:10.1136/gut.43.6.856 · Cited by 349
Influence of Stress and Nutrition on Cattle Immunity
Carroll, J. A., & Forsberg, N. E. (2007) · Veterinary Clinics of North America: Food Animal Practice · doi:10.1016/j.cvfa.2007.01.003 · Cited by 337
Karban, A. S., Okazaki, T., Panhuysen, C. I. M., Gallegos, T., Potter, J. J., Bailey-Wilson, J. E., Silverberg, M. S., Duerr, R. H., Cho, J. H., Gregersen, P. K., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh008 · Cited by 334
Functions of NOD-Like Receptors in Human Diseases
Zhong, Y., Kinio, A., & Saleh, M. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00333 · Cited by 317
Boswellia serrata: An Overall Assessment of In Vitro, Preclinical, Pharmacokinetic and Clinical Data
Abdel-Tawab, M., Werz, O., & Schubert-Zsilavecz, M. (2011) · Clinical Pharmacokinetics · doi:10.2165/11586800-000000000-00000 · Cited by 311
Wehkamp, J., Harder, J., Weichenthal, M., Mueller, O., Herrlinger, K. R., Fellermann, K., Schroeder, J. M., & Stange, E. F. (2003) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200307000-00001 · Cited by 295
van Heel, D. A. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.11.1281 · Cited by 291
Murano, M., Maemura, K., Hirata, I., Toshina, K., Nishikawa, T., Hamamoto, N., Sasaki, S., Saitoh, O., & Katsu, K. (2001) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.2000.01183.x · Cited by 281
Foell, D., Kucharzik, T., Kraft, M., Vogl, T., Sorg, C., Domschke, W., & Roth, J. (2003) · Gut · doi:10.1136/gut.52.6.847 · Cited by 279
Ruiz, P. A., Braune, A., Hölzlwimmer, G., Quintanilla-Fend, L., & Haller, D. (2007) · The Journal of Nutrition · doi:10.1093/jn/137.5.1208 · Cited by 277
Heliö, T., Halme, L., Lappalainen, M., Fodstad, H., Paavola-Sakki, P., Turunen, U., Färkkilä, M., Krusius, T., & Kontula, K. (2003) · Gut · doi:10.1136/gut.52.4.558 · Cited by 270
Curcumin prevents and ameliorates trinitrobenzene sulfonic acid–induced colitis in mice
Sugimoto, K., Hanai, H., Tozawa, K., Aoshi, T., Uchijima, M., Nagata, T., & Koide, Y. (2002) · Gastroenterology · doi:10.1053/gast.2002.37050 · Cited by 262
Schreiber, S., Aden, K., Bernardes, J. P., Conrad, C., Tran, F., Höper, H., Volk, V., Mishra, N., Blase, J. I., Nikolaus, S., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.02.062 · Cited by 259
Self-citationGewirtz, A. T., Collier-Hyams, L. S., Young, A. N., Kucharzik, T., Guilford, W. J., Parkinson, J. F., Williams, I. R., Neish, A. S., & Madara, J. L. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.10.5260 · Cited by 256
Immune dysfunction in inflammatory bowel disease
Neuman, M. G. (2007) · Translational Research · doi:10.1016/j.trsl.2006.11.009 · Cited by 255
Recent understanding of IBD pathogenesis: Implications for future therapies
Kucharzik, T., Maaser, C., Lügering, A., Kagnoff, M., Mayer, L., Targan, S., & Domschke, W. (2006) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000235827.21778.d5 · Cited by 254
Bacteroides thetaiotaomicron Ameliorates Colon Inflammation in Preclinical Models of Crohn’s Disease
Delday, M., Mulder, I., Logan, E. T., & Grant, G. (2019) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy281 · Cited by 193
The Role of NF‐κB in Hypoxia‐Induced Gene Expression
Taylor, C. T., & Cummins, E. P. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05024.x · Cited by 175
Prophylactic systemic P2X7 receptor blockade prevents experimental colitis
Marques, C. C., Castelo-Branco, M. T., Pacheco, R. G., Buongusto, F., do Rosário, A., Schanaider, A., Coutinho-Silva, R., & de Souza, H. S. P. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.10.012 · Cited by 78
Huang, F., Wei, H., Luo, H., Jiang, S., & Peng, J. (2011) · British Journal Of Nutrition · doi:10.1017/s0007114510003703 · Cited by 40
Wang, Y., Lin, Q.-W., Zheng, P.-P., Zhang, J.-S., & Huang, F.-R. (2013) · BioMed Research International · doi:10.1155/2013/318981 · Cited by 38
“Hindawi Publishing Corporation BioMed Research International Volume 2013, Article ID 318981, 9 pages http://dx.doi.org/10.1155/2013/318981”
InfluentialHypoxia and its Emerging Therapeutics in Neurodegenerative, Inflammatory and Renal Diseases
Bhatia, D., Ardekani, M. S., Shi, Q., & Movafagh, S. (2017) · Hypoxia and Human Diseases · doi:10.5772/66089 · Cited by 17
Guarino, M. P. L., Sessa, R., Altomare, A., Cocca, S., Di Pietro, M., Carotti, S., Schiavoni, G., Alloni, R., Emerenziani, S., Morini, S., et al. (2013) · Digestive and Liver Disease · doi:10.1016/j.dld.2013.06.001 · Cited by 15
Metadata
- Authors
- Schreiber, S., Nikolaus, S., & Hampe, J.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 1998-04-01
- Volume
- 42
- Issue
- 4
- Pages
- 477-484
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W1897551156
- Cited by
- 750
- References
- 37
- FWCI
- 11.38
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.